April 24, 2021
Santhera to Announce 2020 Results on April 29, 2021
Pratteln, Switzerland, April 23, 2021 – Santhera Pharmaceuticals (SIX: SANN) will announce its audited 2020 results on Thursday, April 29, 2021, at…
Pharmaceuticals, Biotechnology and Life Sciences
Pratteln, Switzerland, April 23, 2021 – Santhera Pharmaceuticals (SIX: SANN) will announce its audited 2020 results on Thursday, April 29, 2021, at…
New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young…
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful…
Detailed results from Phase 2b study of roflumilast foam in scalp and body psoriasis featured in late-breaking oral presentationData demonstrate…
TORONTO, April 23, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will…
REDWOOD CITY, Calif., April 23, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq: CHRS) has received notice from immuno-oncology partner…
– Edward J. Sitar appointed as Lead Independent Director of the Board – – Company establishes Science and Technology Committee…
SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant…
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives…
If approved, ENSPRYNG will be the first and only treatment available to both adults and adolescents from 12 years of…